This systematic review of 52 epidemiological studies supports a link between plasminogen activator inhibitor-1 and type 2 diabetes, thus highlighting a potentially significant yet under-appreciated risk factor for diabetes. Here, SERPINE1 is linked to diabetes mellitus.